The European Medicines Agency (EMA) has approved two additional manufacturing sites for the production of Pfizer-BioNTech’s Covid vaccine, as well as a new formula, as it considers rolling out the shots for those aged five to 11.

In a statement issued on Monday, the EU’s drug regulator revealed that its human medicines committee (CHMP) has given its seal of approval for two additional manufacturing sites for the production of Comirnaty, the Covid-19 jab developed by the US-German partnership of Pfizer and BioNTech.

Both of the new plants are located in Italy, with one in Monza and the other in Anagni. As per the statement, the sites will produce up to 85 million additional doses to supply the EU in 2021. (RT)